Dog owners can anticipate a new anti-aging pill that has achieved a key FDA milestone for efficacy, with expected market ...
Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility
Granules India’s shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...
The FDA's cancellation of the annual meeting to discuss the next season's flu vaccines has raised significant concerns among ...
US President Donald Trump, who started a 12-month withdrawal process for the US to leave the WHO, has said he may consider ...
The Karnataka Health Ministry is taking strict action to remove low-quality medicines and unsafe food from the market. Through inspections and legal steps, authorities are working to protect public ...
Granules added that manufacturing and distribution of its existing products at the facility will continue unaffected.
The Indian pharma sector has grown at 8 per cent CAGR and has also seen a 9 per cent increase in export rates in 2024, ...
India’s pharma sector, the world's top generic drug supplier, grows at a 9% CAGR, outpacing global rates, with Artificial Intelligence-driven advances set to unlock US$ 60 billion - US$ 110 billion.
Sanofi Indias standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25.
In today’s stock market trade, a slew of stocks will be on investors’ radar, including Tata Power, Life Insurance Corporation ...
The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results